 |
| VOLUME 68 |
2007 |
NUMBER 2 |
To ensure continued delivery, please add MedFair@MedFair.com to your address book.
The Art (and Blood Sport) of Psychopharmacology Research: Who Has
a Dog in the Fight? Alan J. Gelenberg and Marlene P. Freeman
Longitudinal Effects of Personality Disorders on Psychosocial
Functioning of Patients With Major Depressive Disorder. John C.
Markowitz, Andrew E. Skodol, Eva Petkova,
Jianfeng Cheng, Charles A. Sanislow, Carlos M. Grilo,
John G. Gunderson, and Thomas H. McGlashan
Persisting Low Use of Antipsychotics in the Treatment of Major
Depressive Disorder With Psychotic Features. Carmen Andreescu,
Benoit H. Mulsant,
Catherine Peasley-Miklus, Anthony J. Rothschild, Alastair J.
Flint, Moonseong Heo, Melynda Caswell, Ellen M. Whyte, and Barnett
S. Meyers, for the STOP-PD Study Group
Efficacy and Safety of Topiramate Monotherapy in Civilian
Posttraumatic Stress Disorder: A Randomized, Double-Blind,
Placebo-Controlled Study. Phebe Tucker, Richard P. Trautman,
Dorothy B. Wyatt, Jamie Thompson, Shu-Chen Wu, Julie A. Capece,
and Norman R. Rosenthal
Aripiprazole for Treatment-Resistant Schizophrenia: Results of
a Multicenter, Randomized, Double-Blind, Comparison Study Versus
Perphenazine. John M. Kane, Herbert Y. Meltzer, William H.
Carson, Jr., Robert D. McQuade, Ronald N. Marcus, and
Raymond Sanchez, for the Aripiprazole Study Group
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine
Combination, Olanzapine, and Fluoxetine in Treatment-Resistant
Major Depressive Disorder. Michael E. Thase, Sara A. Corya,
Olawale Osuntokun, Michael Case, David B. Henley, Todd M. Sanger,
Susan B. Watson, and Sanjay Dubé
Melatonin in Schizophrenic Outpatients With Insomnia: A
Double-Blind, Placebo-Controlled Study. P. N. Suresh Kumar,
Chittaranjan Andrade, Savita G. Bhakta, and Nagendra M. Singh
Predictors of Suicide in First-Episode Affective and
Nonaffective Psychotic Inpatients: Five-Year Follow-Up of Patients
From a Catchment Area in Vitoria, Spain. Ana González-Pinto,
Ana Aldama, Cristina González, Fernando Mosquera, Marta Arrasate,
and Eduard Vieta
Impact of Comorbid Attention Deficit Disorder on the Direct
Medical Costs of Treating Adults With Depression in Managed Care.
Paul A. Fishman, Paul E. Stang, and Susan L. Hogue
A Comparison of Rates of Residual Insomnia Symptoms Following
Pharmacotherapy or Cognitive-Behavioral Therapy for Major
Depressive Disorder. Colleen E. Carney, Zindel V. Segal, Jack
D. Edinger, and Andrew D. Krystal
Effect of Bupropion Extended Release on Negative Emotion
Processing in Major Depressive Disorder: A Pilot Functional
Magnetic Resonance Imaging Study. Brigitte Robertson, Lihong
Wang, Michele T. Diaz, Marilyn Aiello, Kenneth Gersing, John
Beyer,
Srinivasan Mukundan, Jr., Gregory McCarthy, and P. Murali
Doraiswamy
Efficacy of a Novel Biphasic Controlled-Release Methylphenidate
Formula in Adults With Attention-Deficit/Hyperactivity Disorder:
Results of a Double-Blind, Placebo-Controlled Crossover Study.
Umesh Jain, Lily Hechtman, Margaret Weiss,
Tahira S. Ahmed, Joseph L. Reiz, Graeme A. E. Donnelly, Zoltan
Harsanyi, and Andrew C. Darke
Are Day Hospitals Effective for Acutely Ill Psychiatric
Patients? A European Multicenter Randomized Controlled Trial.
Thomas W. Kallert, Stefan Priebe, Rosemarie McCabe, Andrzej Kiejna,
Joanna Rymaszewska, Petr Nawka, Ladislav Oăvár, Jií Raboch, Lucie
Stárková-Kaliová, Rainer Koch, and Matthias Schützwohl
Nefazodone in the Treatment of Generalized Social Phobia: A
Randomized, Placebo-Controlled Trial. Michael Van Ameringen,
Catherine Mancini, Jonathan Oakman, John Walker, Kevin Kjernisted,
Pratap Chokka, David Johnston, Mark Bennett,
and Beth Patterson
Focus on Childhood and Adolescent Mental Health
Can Research Inform the Clinical Care of Mental Health
Disorders in Children and Adolescents? Melissa P. DelBello
Adaptive Functioning and Psychiatric Symptoms in Adolescents
With Borderline Personality Disorder. Andrew M. Chanen, Martina
Jovev, and Henry J. Jackson
Diagnostic Characteristics of Child Bipolar I Disorder: Does
the "Treatment of Early Age Mania (TEAM)" Sample Generalize?
Rebecca Tillman and Barbara Geller
This article is part of the
CME Activity
for February.
Health-Related Quality of Life in Euthymic Bipolar Disorder
Patients: Differences Between Bipolar I and II Subtypes.
[CME] Giuseppe Maina, Umberto Albert, Laura Bellodi,
Cristina Colombo, Carlo Faravelli, Palmiero Monteleone, Filippo
Bogetto, Giovanni B. Cassano, and Mario Maj
Academic Highlights: Transcranial Magnetic Stimulation:
Potential New Treatment for Resistant Depression.[CME]
The Psychopharmacology of Violence With Emphasis on
Schizophrenia, Part 2: Long-Term Treatment. Leslie Citrome
A Discussion of 2 Double-Blind Studies Comparing Risperidone and
Quetiapine in
Patients With Schizophrenia. Georges M. Gharabawi, Cynthia A.
Bossie, Gahan J. Pandina, Mary J. Kujawa, Andrew J. Greenspan, and
Young Zhu
· Reply by Dennis E. Sweitzer, Arthur Lazarus, and Martin
Brecher
Indexing of Reports on Aripiprazole Augmentation of
Clozapine. Adam Keller Ashton
· Reply by Harpreet S. Duggal and Dattatreya N. Mendhekar
Successful Use of Phenelzine in Treatment-Resistant Panic
Disorder. Sandip Buch and Michael Wagner
Azithromycin and Catatonic Symptoms. Niraj Ahuja
· Reply by Maria Teresa Plana and Jordi Blanch
Delayed Sleep Phase Syndrome, ADHD, and Bright Light Therapy.
Reut Gruber, Natalie Grizenko, and Ridha Joober
Correction. Freeman MP, Hibbeln JR, Wisner KL, Davis JM,
Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ,
Lake J, and Stoll AL. Omega-3 fatty acids: evidence basis for
treatment and future research in psychiatry (J Clin Psychiatry
2006;67:1954-1967)
Handbook of Psychiatric Drug Therapy, 5th ed. Reviewed by Catherine Chiles, M.D.
Community Child and Adolescent Psychiatry: A Manual
of Clinical Practice and Consultation. Reviewed by Richard M. Sarles, M.D.
Infant and Early Childhood Mental Health:A Comprehensive Developmental Approach to
Assessment and Intervention. Reviewed by Mary W. Roberts, M.D.
Fatal Flaws: Navigating Destructive Relationships With People With Disorders of Personality and Character. Reviewed by Frederick J. Stoddard, Jr., M.D.
Learning Cognitive-Behavior Therapy: An Illustrated Guide. Reviewed by Barry M. Morenz, M.D.
Find these activities at
www.psychiatrist.com
A History of the Concept of Atypical Depression. Jonathan R.
T. Davidson and Michael E. Thase
Effectiveness of Antipsychotic Drugs in Patients With Chronic
Schizophrenia: Efficacy, Safety, and Cost Outcomes of CATIE and
Other Trials. Jeffrey A. Lieberman
Cost-Effectiveness Measures, Methods, and Policy Implications
From the Clinical Antipsychotic Trials of Intervention
Effectiveness (CATIE) for Schizophrenia. Robert A. Rosenheck
and Jeffrey A. Lieberman |
